发明名称 |
USE OF EDG RECEPTOR BINDING AGENTS IN CANCER |
摘要 |
Provided is a method for treating solid tumors, e.g tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent. |
申请公布号 |
AU2003240655(A1) |
申请公布日期 |
2003.12.02 |
申请号 |
AU20030240655 |
申请日期 |
2003.05.15 |
申请人 |
NOVARTIS AG |
发明人 |
THOMAS BAUMRUKER;VOLKER BRINKMANN;KENNETH, RICHARD LA MONTAGNE;PETER, T. LASSOTA;DIANA MECHTCHERIAKOVA;JEANETTE, MARJORIE WOOD |
分类号 |
A61K45/00;A61K31/135;A61K31/137;A61K31/381;A61K31/661;A61P9/00;A61P35/00;A61P35/04;A61P43/00;(IPC1-7):A61K31/135 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|